-
Cost-Effectiveness of Adjuvant Alectinib vs. Platinum-Based Chemotherapy in Resected Stage IB-IIIA ALK-Positive NSCLC: A French Health Economic Evaluation
Sep 9, 2025, 16:22 PM -
Defining Unavoidable Uncertainty in HTA: Towards More Flexible and Adapted Approaches for Promising Treatments
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Aztreonam Avibactam (ATMAVI) ± Metronidazole (MTZ) for the Treatment of Complicated Intra-Abdominal Infections (cIAIs) and Ventilator-Associated Hospital-Acquired Pneumonia (HAP/VAP) Caused by Suspected MBL-Producing...
Sep 9, 2025, 16:22 PM -
Pragmatic Advice to Improve Assessment Schedule of Preference-Based Measures of Health to Estimate Utilities in Clinical Trials
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Sep 9, 2025, 16:22 PM -
The Innovative Licensing and Access Pathway (ILAP): Early Pathway Experience, Examining, Process Adaptations, and Industry Impact
Sep 9, 2025, 16:22 PM -
Comparison of the Early Access and Postmarket Evaluation Systems in South Korea and Germany’s DIGA
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of High-Dose Trivalent Influenza Vaccine in the Elderly: A Cohort-Based Economic Model From the Italian NHS Perspective
Sep 9, 2025, 16:22 PM -
Does the Joint Clinical Assessment (JCA) Enable Health Equity Across Europe? A Review of HTA Practices in the EU
Sep 9, 2025, 16:22 PM -
The Socioeconomic Burden of Dengue in Spain
Sep 9, 2025, 16:22 PM -
Impact of Mucus Plugs on the Health Economic Burden in Chronic Obstructive Pulmonary Disease (COPD) Patients
Sep 9, 2025, 16:22 PM -
The Economic Burden of Moderate and Severe Anxiety and Depression Symptoms in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Positioning of the Eluvia™, Drug-Eluting Stent in the Treatment of Peripheral Artery Disease (PAD) in Türkiye: Insights From a Specialist Panel Survey and Focus Group Study
Sep 9, 2025, 16:22 PM -
Optimizing a New Patient-Reported Outcome Instrument for Proliferative Diabetic Retinopathy: A Psychometric Study
Sep 9, 2025, 16:22 PM -
Real-life-Persistence to Antifibrotic Treatments in the French Population
Sep 9, 2025, 16:22 PM -
Incorporating Equity-of-Access Into Health Economic Evaluations: Surgical Task-Shifting for C-Sections in Sierra Leone
Sep 9, 2025, 16:22 PM -
UDCA Treatment Response in Primary Biliary Cholangitis in the United States
Sep 9, 2025, 16:22 PM -
Economic Impact of Incorporating a Fecal Bacterial Signature to Optimize FIT-Based Colorectal Cancer Screening in Spain
Sep 9, 2025, 16:22 PM -
Correlation Between Ultra-Orphan Drug Costs Cost-Effectiveness Metrics and Disease Prevalence
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on Healthcare Resource Utilization (HCRU) Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM
